A61K 51/0408
Phospholipids
Official title: {Phospholipids (liposomes encapsulating the radioactive probe or having no radiolabelled phospholipids A61K51/1231)}
A61K51/0408 (Phospholipids) appears on 30 US grants and 59 published applications in this corpus.
Search patents in A61K- Granted patents
- 30
- Published applications
- 59
- Assignees
- 31
- Inventors
- 91
- Latest grant
- 24 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 2 | 2 |
| 2014 | 2 | 3 |
| 2015 | 1 | 3 |
| 2016 | 2 | 2 |
| 2017 | 3 | 3 |
| 2018 | 2 | 5 |
| 2019 | 0 | 2 |
| 2020 | 3 | 7 |
| 2021 | 2 | 1 |
| 2022 | 0 | 4 |
| 2023 | 3 | 2 |
| 2024 | 1 | 3 |
| 2025 | 1 | 6 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Glutaminase inhibitor therapy24 Jun 2025US 12,336,976 B2Board of Regents, The University of Texas System
- Radiohalogenated agents for in situ immune modulated cancer vaccination8 Oct 2024US 12,109,256 B2Wisconsin Alumni Research Foundation
- Glutaminase inhibitor therapy17 Oct 2023US 11,786,500 B2Board of Regents, The University of Texas System
- Targeted radiotherapy chelates for in situ immune modulated cancer vaccination22 Aug 2023US 11,730,834 B2Wisconsin Alumni Research Foundation
- Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies25 Apr 2023US 11,633,506 B2Wisconsin Alumni Research Foundation
- Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies11 Jun 2026US 2026/0158176 A1Wisconsin Alumni Research Foundation
- Radiolabeled liposomes and methods of use for treating leptomeningeal metastases23 Oct 2025US 2025/0325715 A1NanoTx, Corp.
- Methods for inhibiting trained immunity with nanobiologic compositions3 Jul 2025US 2025/0213665 A1Icahn School of Medicine at Mount Sinai
- Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies19 Jun 2025US 2025/0195701 A1Wisconsin Alumni Research Foundation
- Treatment of cancers with a regimen of targeted radionuclide therapy and dual car t cell therapy29 May 2025US 2025/0170180 A1Wisconsin Alumni Research Foundation
Most cited
By later US patents
- Radioiodinated phospholipid ether analogues35US 4,965,391 AUniversity of Michigan · 1990
- Radioiodinated phosphate esters29US 5,087,721 AUniversity of Michigan · 1992
- Virtual colonoscopy with radiolabeled phospholipid ether analogs20US 7,700,075 B2Cellectar, Inc. · 2010
- Radioiodinated phospholipid ether analogues and methods of using same18US 5,347,030 AThe Board of Regents of the University of Michigan · 1994
- Radioiodinated phospholipid ether analogs and methods of using the same16US 6,417,384 B1The Regents of the University of Michigan · 2002